Back to Search
PATRICIA GREIPP, D.O.
D.O.
Clinical Pathology/Laboratory Medicine Physician
NPI: 1912122839IndividualAccepts Medicare
Specialties, Licenses & Credentials
Hematology & Oncology Physician
Internal Medicine — Hematology & Oncology
Code: 207RH0003X
43936(MN)
Clinical Pathology/Laboratory Medicine PhysicianPrimary
Pathology — Clinical Pathology/Laboratory Medicine
Code: 207ZP0105X
43936(MN)
Education
PHILADELPHIA COLLEGE OF OSTEOPATHIC MEDICINE
Class of 1997
Research & Publications (20)
Treatment paradigms for the newly diagnosed patient with multiple myeloma.
PMID 16344097·Semin Hematol·2005
6-review
Prognostic indicators for the diagnosis of multiple myeloma.
PMID 15209186·Oncology (Williston Park)·2004
8-other
Prevalence, breakpoint distribution, and clinical correlates of t(5;12).
PMID 15350308·Cancer Genet Cytogenet·2004
8-other
Smoldering, asymptomatic stage 1, and indolent myeloma.
PMID 12057049·Curr Treat Options Oncol·2000
6-review
Clinical outcome of immunoglobulin light chain amyloidosis affecting the kidney.
PMID 19403931·Nephrol Dial Transplant·2009
8-other
The treatment of multiple myeloma using vincristine, carmustine, melphalan, cyclophosphamide, and prednisone (VBMCP) alternating with high-dose cyclophosphamide and alpha(2)beta interferon versus VBMCP: results of a phase III Eastern Cooperative Oncology Group Study E5A93.
PMID 19248045·Cancer·2009
3-trial
Induction of a chronic disease state in patients with smoldering or indolent multiple myeloma by targeting interleukin 1{beta}-induced interleukin 6 production and the myeloma proliferative component.
PMID 19181644·Mayo Clin Proc·2009
3-trial
Identification of copy number abnormalities and inactivating mutations in two negative regulators of nuclear factor-kappaB signaling pathways in Waldenstrom's macroglobulinemia.
PMID 19351844·Cancer Res·2009
8-other
Impact of risk stratification on outcome among patients with multiple myeloma receiving initial therapy with lenalidomide and dexamethasone.
PMID 19324902·Blood·2009
8-other
Translocation t(11;14) and survival of patients with light chain (AL) amyloidosis.
PMID 19211640·Haematologica·2009
8-other
A Phase II trial of autologous stem cell transplantation followed by mini-allogeneic stem cell transplantation for the treatment of multiple myeloma: an analysis of Eastern Cooperative Oncology Group ECOG E4A98 and E1A97.
PMID 19135946·Biol Blood Marrow Transplant·2009
3-trial
Phase II study of interleukin-12 for treatment of plateau phase multiple myeloma (E1A96): a trial of the Eastern Cooperative Oncology Group.
PMID 19243818·Leuk Res·2009
3-trial
A novel report of cig-FISH and cytogenetics in POEMS syndrome.
PMID 18839437·Am J Hematol·2008
8-other
Genomic variation in myeloma: design, content, and initial application of the Bank On A Cure SNP Panel to detect associations with progression-free survival.
PMID 18778477·BMC Med·2008
8-other
Clinical impact of discordance in serum albumin measurements on myeloma international staging system.
PMID 18711203·J Clin Oncol·2008
8-other
Long-term risk of myelodysplasia in melphalan-treated patients with immunoglobulin light-chain amyloidosis.
PMID 18641023·Haematologica·2008
8-other
Prognostic value of the serum free light chain ratio in newly diagnosed myeloma: proposed incorporation into the international staging system.
PMID 18596742·Leukemia·2008
8-other
Clinical and biological significance of RAS mutations in multiple myeloma.
PMID 18528420·Leukemia·2008
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 200 1ST ST SW
ROCHESTER, MN 55905 - Phone
- (507) 284-2511
Quick Facts
- NPI
- 1912122839
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 1
- Years in Practice
- 29
- Publications
- 20
Are you this provider?
Claim Your Profile